Effect of a New Formulation of Nutraceuticals as an Add-On to Metformin Monotherapy for Patients with Type 2 Diabetes and Suboptimal Glycemic Control: A Randomized Controlled Trial

Effect of a New Formulation of Nutraceuticals as an Add-On to Metformin Monotherapy for Patients with Type 2 Diabetes and Suboptimal Glycemic Control: A Randomized Controlled Trial

The aim of the study was to evaluate the overall biohumoral and metabolic effects of a 12-week add-on therapy consisting of a new nutraceutical formulation (BHC) based on berberine, hesperidin, and chromium picolinate in type 2 diabetes mellitus (T2D) patients with suboptimal glycemic compensation r...

Full description

Bibliographic Details
Main Authors: Giovanni Sartore, Eugenio Ragazzi, Giulia Antonello, Chiara Cosma, Annunziata Lapolla
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Nutrients
Subjects:
advanced glycation end products
berberine
hesperidin
glyco-oxidation
Online Access:https://www.mdpi.com/2072-6643/13/7/2373

Similar Items

Similar Items